Tagot, John Mark A.
HRN: 01-85-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2026
CEFTRIAXONE 1G (VIAL)
08/14/2026
08/21/2026
IV
2g
OD
Acute Pyelonephritis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: